California Institute for regenerative medicine
The State stem cell agency

Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.

Journal: 
Nat Neurosci
Publication Year: 
2011
Funding Grants: 
Training Program in Stem Cell Research